Escape of HIV-1 from a CCR5 antagonist can reduce envelope-mediated entry

被引：0
|
作者：
Huang, W. [1 ]
Wojcik, L. [2 ]
Toma, J. [1 ]
Fransen, S. [1 ]
Stawiski, E. [1 ]
Whitcomb, J. [1 ]
Parkin, N. [1 ]
Strizki, J. [2 ]
Petropoulos, C. [1 ]
机构：
[1] Monogram Biosci, San Francisco, CA USA
[2] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A65 / A65
页数：1
相关论文
共 50 条
  • [21] Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
    Atchison, RE
    Gosling, J
    Monteclaro, FS
    Franci, C
    Digilio, L
    Charo, IF
    Goldsmith, MA
    SCIENCE, 1996, 274 (5294) : 1924 - 1926
  • [22] Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
    Berro, Reem
    Sanders, Rogier W.
    Lu, Min
    Klasse, Per J.
    Moore, John P.
    PLOS PATHOGENS, 2009, 5 (08)
  • [23] Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1
    Nakano, Yusuke
    Monde, Kazuaki
    Terasawa, Hiromi
    Yuan, Yuzhe
    Yusa, Keisuke
    Harada, Shinji
    Maeda, Yosuke
    VIROLOGY, 2014, 452 : 117 - 124
  • [24] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [25] Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues
    Bewley, CA
    Ray, S
    Cohen, F
    Collins, SK
    Overman, LE
    JOURNAL OF NATURAL PRODUCTS, 2004, 67 (08): : 1319 - 1324
  • [26] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [27] V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc
    Berro, Reem
    Klasse, Per Johan
    Moore, John P.
    Sanders, Rogier W.
    VIROLOGY, 2012, 427 (02) : 158 - 165
  • [28] Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32
    Benkirane, M
    Jin, DY
    Chun, RF
    Koup, RA
    Jeang, KT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30603 - 30606
  • [29] Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient
    Gorry, Paul R.
    Ahmad, Fahim
    Mohl, Jon
    Alkhatib, Ghalib
    AIDS, 2018, 32 (16) : 2269 - 2278
  • [30] HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
    Pugach, Pavel
    Marozsan, Andre J.
    Ketas, Thomas J.
    Landes, Elissa L.
    Moore, John P.
    Kuhmann, Shawn E.
    VIROLOGY, 2007, 361 (01) : 212 - 228
12345